Improvements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis
Bioorganic & Medicinal Chemistry · 2026-07 · 138 · 118643
DOI: 10.1016/j.bmc.2026.118643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026-07. Verfasst von Timothy J Borel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Vahlteich Medicinal Chemistry Core, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, United States. Hauptthemen laut MEDLINE: Cathepsin L, Triazines, Nitriles, Toxoplasma. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Michigan, University of Michigan College of Pharmacy.
Abstract (Originalsprache)
The protozoan Toxoplasma gondii is one of the most prevalent infectious agents, having infected approximately one third of the global population. It remains a leading cause of deaths due to foodborne illness, can cause serious complications in immunocompromised and pregnant women, and is associated with vision loss and mental illnesses including schizophrenia and major depressive disorder. Current treatments target symptoms associated with the acute, fast-replicating form of the parasite, but fail to clear the body of the chronic, slow-replicating form of the parasite that persists in tissues, including the central nervous system (CNS). In this study, we report efforts to improve the selectivity of previously reported triazine nitrile inhibitors of T. gondii cathepsin protease L over human cathepsin L. With the help of computational modeling, different structural design approaches were used to improve inhibitor potency and selectivity including conformationally restricted scaffold modifications, basic and polar groups, and nonaromatic groups. From these approaches, we maintained strong inhibitor potency (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vahlteich Medicinal Chemistry Core, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, United States.
- Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, United States.
- Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address: vcarruth@umich.edu.
- Vahlteich Medicinal Chemistry Core, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, United States. Electronic address: mclasby@umich.edu.
Förderung
- University of Michigan
- University of Michigan College of Pharmacy
Zitieren
APA
Borel, T. J., Hitchens, J. R., Kaur, H., Mueller, D., Ard, A., Carruthers, V. B., & Clasby, M. C. (2026). Improvements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis. Bioorganic & Medicinal Chemistry, 138, 118643. https://doi.org/10.1016/j.bmc.2026.118643
Vancouver
Borel TJ, Hitchens JR, Kaur H, Mueller D, Ard A, Carruthers VB, et al. Improvements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis. Bioorganic & Medicinal Chemistry. 2026;138:118643. doi:10.1016/j.bmc.2026.118643
BibTeX
@article{Borel2026,
author = {Borel, Timothy J and Hitchens, Jacob R and Kaur, Hargobinder and Mueller, David and Ard, Adam and Carruthers, Vern B and Clasby, Martin C},
title = {Improvements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis},
journal = {Bioorganic & Medicinal Chemistry},
year = {2026},
volume = {138},
pages = {118643},
doi = {10.1016/j.bmc.2026.118643}
}
EUVIMED